This week is all about ‘the Top’… we look at the top selling approved and launched drugs of 2012, the top biopharma duds from the last 5 years, the transformation of IMS Health, hurdles and opportunities in pharma emerging markets and the big questions on what to do with Big Data:
– What new medicines are shaking things up? Gen provides the answers in Top 20 Best-Selling Drugs Approved and Launched During 2012, a listing of the top 20 best-selling drugs that were approved and launched during 2012, ranked by their 2012 sales
– On the flip side, FierceBiotech shares Analysts Rank the Top 10 Blockbuster Duds in Biopharma, the top 10 blockbuster busts – new drugs which in the last 5 years were expected to rake in a fortune only to fall far short. The list is based on original projections versus current forecasts or actual revenue
– Global pharma market researcher IMS Health Inc. is transforming itself into a health informatics and advisory company, expanding its service focus to the entire healthcare sector. IMS Health to Broaden Focus to Hospital, Insurance Solutions from Livemint explains the new areas of consultancy to the pharmaceuticals and hospital industry, advisory and data services to health insurance companies and government policy assistance
– Booz & Company set out to better understand both the challenges faced by the global pharmaceutical industry in its pursuit of emerging-market opportunities and the strategies that leaders are employing to address them. Pharma Emerging Markets 2.0: How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry offers a look at the hurdles and opportunities Pharma faces in pursuing perhaps its best opportunity for growth
– It’s not the data, it’s what you do with it. BarnRaisers put together 20 Big Questions to be Asking About Big Data to help you see the potential Big Data has on your business as well as your company’s values and culture
That wraps this week’s review of news from and for the pharma market research community. I’ll leave you with an invitation to learn more about the benefits of real time data and offer you a personal demo of InCrowd’s on-demand platform providing you direct and immediate access to Crowds of screened and targeted healthcare professionals.
If you have tips, suggestions, or resources you’d like to share leave us a comment below and please feel free to suggest topics that you’d like to see covered in future posts.
